Plasma dipeptidyl peptidase IV activity and measures of body composition in apparently healthy people

AIM: Based on its regulatory action on glucagon-like peptide 1, dipeptidyl peptidase IV (DPP-IV) has increasingly been linked to Type 2 diabetes. However, there is no evidence as to how this normal modulatory enzyme leads to pathology. It is thought that DPP-IV is affected by the development of obes...

Descripción completa

Detalles Bibliográficos
Autores principales: Neidert, Leslie E., Wainright, Katherine S., Zheng, Chen, Babu, Jeganathan Ramesh, Kluess, Heidi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946079/
https://www.ncbi.nlm.nih.gov/pubmed/27441271
http://dx.doi.org/10.1016/j.heliyon.2016.e00097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946079/
https://www.ncbi.nlm.nih.gov/pubmed/27441271
http://dx.doi.org/10.1016/j.heliyon.2016.e00097

Ejemplares similares